Sort
78,016 grants matching “breast cancer”
TESTING NOVEL DRUGS TARGETING THE BETA-III-TUBULIN ISOTYPE IN BREAST CANCER
$461,751The University Of Texas Health Science Center At San Antonio · · FY2010 · Department of Defense
RELIEVING IMMUNE-SUPPRESSIVE PATHWAYS IN BREAST CANCER TO IMPROVE OUTCOMES
$461,746Oregon Health & Science University · · FY2020 · Defense Health Agency
Development of genetically encoded sex hormone biosensors to understand neuroactive steroid signaling dynamics in vivo
$461,714Andre Berndt · University Of Washington · R21 · FY2025 · MH
EPIGENETIC BASIS FOR THE REGULATION OF ESTROGEN RECEPTOR ALPHA ACTIVITY IN BREAST CANCER CELLS
$461,700Dana-Farber Cancer Institute, Inc. · · FY2008 · Department of the Army
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion
$461,646Xiang Zhang · Baylor College Of Medicine · R01 · FY2024 · CA
IBCSG STATISTICAL CENTER--A BREAST CANCER STUDY RESOURCE
$461,626Dana-Farber Cancer Institute · U24 · FY2004 · CA
Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared Flu
$461,610Hak Soo Choi · Beth Israel Deaconess Medical Center · R01 · FY2013 · EB
Endocrine Disrupting Chemicals and Breast Density in Nulliparous College-Aged Women
$461,573Susan R Sturgeon · University Of Massachusetts Amherst · R15 · FY2019 · ES
Combinational Environmental Chemicals Altering Susceptibility for Mammary Cancer
$461,572Coral Lamartiniere · University Of Alabama At Birmingham · U01 · FY2011 · ES
Prediagnostic exposures, germline genetics, and triple negative breast cancer mutational and immune profiles
$461,561Rulla M Tamimi · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · CA
Interactive CD-ROM for Coping with Breast Cancer
$461,537Mpower Llc · R44 · FY2005 · CA
MAINLINE HEALTH CCOP
$461,522Lankenau Institute For Medical Research · U10 · FY2004 · CA
The Radiation Planning Assistant (RPA) for Radiation Therapy Planning in Low- and Middle-Income Countries
$461,512Laurence E Court · University Of Tx Md Anderson Can Ctr · UH2 · FY2017 · CA
avb6-directed molecular imaging and therapy
$461,496Julie L Sutcliffe · University Of California At Davis · R01 · FY2016 · CA
Regulation of metastatic progression by an endothelial-derived factor
$461,474Sohail F. Tavazoie · Rockefeller University · R01 · FY2022 · CA
Further Development of Multi-Antigen, Multi-Peptide Vaccine based on Gene Expression Information to Prevent Triple Negative Breast Cancer in a Mouse Model
$461,468Yian Wang · Medical College Of Wisconsin · N01 · FY2018 · CA
TGF-beta Suppression and Promotion of Mammary Carcinomas
$461,448Harold L Moses · Vanderbilt University · R01 · FY2011 · CA
Mechanism of LSD1 Function and Its Therapeutic Application for Progressive Oral Malignancy
$461,416Manish Bais · Boston University Medical Campus · R01 · FY2025 · DE
CT Monitoring of Angiogenesis
$461,348Benjamin M Yeh · University Of California, San Francisco · R01 · FY2009 · CA
Cervical Cancer Control in Vietnamese Women
$461,344Fred Hutchinson Cancer Research Center · R01 · FY2005 · CA
Discovering the role of YES1 in triple negative breast cancer
$461,334Ruth A Keri · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · CA
Discovering the role of YES1 in triple negative breast cancer
$461,334Ruth A Keri · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA
Understanding the Impact of Microscale and Nanoscale Heterogeneity and Resistance
$461,333Joe W. Gray · Oregon Health & Science University · U54 · FY2020 · CA
Targeting MUC5AC mucin in breast cancer brain metastasis
$461,300Mohd Wasim Nasser · University Of Nebraska Medical Center · R01 · FY2025 · CA
Mechanism of p53-dependent Tumor Suppression
$461,263Xinbin Chen · University Of California At Davis · R01 · FY2020 · CA